封面
市場調查報告書
商品編碼
1722845

2025 年至 2033 年連續血糖監測系統市場規模、佔有率、趨勢及預測(按組件、人口統計、最終用戶和地區分類)

Continuous Glucose Monitoring Systems Market Size, Share, Trends and Forecast by Component, Demographics, End User, and Region, 2025-2033

出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球連續血糖監測系統市場規模價值 70.4 億美元。展望未來, IMARC Group估計到 2033 年市場規模將達到 109.2 億美元,2025 年至 2033 年的複合年成長率為 4.75%。北美目前佔據市場主導地位,2024 年的市佔率將超過 38.7%。 CGM 設備的認知度和採用率不斷提高、糖尿病盛行率不斷上升、CGM 設備的重大技術進步以及向預防性醫療保健的持續轉變是推動連續血糖監測系統市場佔有率成長的一些因素。

連續血糖監測系統 (CGMS) 是一種技術先進的設備,可自動追蹤血糖水平。它們由發射器整合感測器組成,該感測器透過經皮或皮下途徑連續測量組織液中的葡萄糖濃度。然後,發射器將訊息發送到可以夾在衣服上的無線監視器。持續血糖監測系統有助於提供糖尿病的完整概況,提醒血糖水平的高低,檢測模式,並增加患者對身體活動、藥物選擇、食物份量和壓力的洞察力。與傳統的血糖監測設備相比,CGMS 無需刺痛,可以直接放置在皮膚上,有助於快速無痛地提供即時資訊。

持續血糖監測系統市場趨勢:

全球範圍內老年人口的不斷增加使得患糖尿病的可能性增大,這為市場帶來了積極的前景。 CGMS 通常用於測量體內的葡萄糖和胰島素水平,如果其下降或上升到危險水平,則會進一步發出警報。與此一致,廣泛使用產品來即時識別低血糖和高血糖情況有利於市場成長。此外,有助於檢測糖尿病患者的糖化血紅蛋白 (Hb1ac) 的 CGMS 的重大改進和新技術進步為市場成長提供了相當大的推動力。此外,人工胰臟裝置系統與 CGMS 技術的結合可以泵送胰島素並給予最佳劑量以管理患者的血糖水平,從而對市場成長產生積極影響。除此之外,非侵入性 CGMS 設備作為一種便捷的替代方案的引入、廣泛的研究和開發 (R&D) 活動以及對少創或微創診斷工具的不斷成長的需求預計將推動市場進一步成長。

本報告回答的關鍵問題

  • 持續血糖監測系統市場有多大?持續血糖監測系統市場的未來前景如何?
  • 推動持續血糖監測系統市場發展的關鍵因素有哪些?
  • 哪個地區佔據連續血糖監測系統最大的市佔率?
  • 全球連續血糖監測系統市場領先的公司有哪些?

目錄

第1章:前言

第2章:範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章:執行摘要

第4章:簡介

  • 概述
  • 主要行業趨勢

第5章:全球連續血糖監測系統市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章:市場細分:按組成部分

  • 感應器
  • 發射器和接收器
  • 整合胰島素泵

第7章:市場區隔:依人口統計

  • 兒童人口(<=14歲)
  • 成年人口(14歲以上)

第8章:市場區隔:按最終用戶

  • 診所和診斷中心
  • 重症監護室
  • 家庭醫療保健

第9章:市場細分:依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔:依國家

第10章:SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章:價值鏈分析

第 12 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章:價格分析

第 14 章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • A. Menarini Diagnostics Srl
    • Abbott Laboratories
    • DexCom Inc.
    • F. Hoffmann-La Roche AG
    • Glysens Incorporated
    • LifeScan Inc. (Johnson & Johnson)
    • Medtronic PLC
    • Medtrum Technologies Inc.
    • Nemaura Medical Inc.
    • Novo Nordisk A/S
    • Senseonics Holdings Inc.
    • Waveform Technologies Inc.
Product Code: SR112025A5377

The global continuous glucose monitoring systems market size was valued at USD 7.04 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 10.92 Billion by 2033, exhibiting a CAGR of 4.75% from 2025-2033. North America currently dominates the market, holding a market share of over 38.7% in 2024. The increasing awareness and adoption of CGM devices, rising prevalence of diabetes, significant technological advancements in CGM devices, and ongoing shift towards preventive healthcare are some of the factors boosting the continuous glucose monitoring systems market share.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Key Market Segmentation:

Breakup by Component:

  • Sensors
  • Transmitters and Receivers
  • Integrated Insulin Pumps

Breakup by Demographics:

  • Child Population (<=14 years)
  • Adult Population (>14 years)

Breakup by End User:

  • Clinics and Diagnostics Centers
  • ICUs
  • Home Healthcare

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Key Questions Answered in This Report

  • 1.How big is the continuous glucose monitoring systems market?
  • 2.What is the future outlook of continuous glucose monitoring systems market?
  • 3.What are the key factors driving the continuous glucose monitoring systems market?
  • 4.Which region accounts for the largest continuous glucose monitoring systems market share?
  • 5.Which are the leading companies in the global continuous glucose monitoring systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Continuous Glucose Monitoring Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Sensors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transmitters and Receivers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Integrated Insulin Pumps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Demographics

  • 7.1 Child Population (<=14 years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Adult Population (>14 years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Clinics and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 ICUs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Healthcare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 A. Menarini Diagnostics S.r.l.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Abbott Laboratories
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DexCom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Glysens Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 LifeScan Inc. (Johnson & Johnson)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Medtronic PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtrum Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Nemaura Medical Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Senseonics Holdings Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Waveform Technologies Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2024
  • Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2024
  • Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2024
  • Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
  • Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
  • Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million USD), 2025-2033
  • Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million USD), 2025-2033
  • Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
  • Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players